MEDICAL IP to attract investment in Series C... Partnership with Dong-A Socio Holdings

MEDICAL IP attracts 20 billion KRW Series C investment

▶ Expected to strengthen competitiveness in the medical market through partnership with Dong-A Socio Holdings, which participated in SI

Medicalip Series C

MEDICALIP has completed attracting 20 billion won of Series C investment.

In particular, Dong-A Socio Holdings, which has many affiliates in the medical field such as Dong-A ST and Dong-A Pharmaceutical, participated as a strategic investor in this investment MEDICAL IP expected to strengthen competitiveness in the medical field and expand the market in earnest.

Dong-A Socio Holdings plans to join with MEDICALIP to foster artificial intelligence healthcare business and create new business opportunities.

CEO Park Sang-joon said, “MEDICALIP is building a differentiated business model that can predict and even monitor diseases using medical AI.”

He continued, “Both FI and SI highly evaluated the company’s technological competitiveness, and we successfully attracted a total of KRW 20 billion in investment. By using this, we will strive to advance the technology, commercialize medical AI products, and enter the global healthcare market.”


Sep 15 / 2023

MEDICAL IP won the ‘Innovation Grand Prize’ at the <KHF Innovation Award>

Aug 31 / 2023

Changing the ‘Future of anatomy’ through MEDICAL IP's AI and digital twin technology

Aug 8 / 2023

MEDICAL IP, Selected as Gartner's Sample Vendor for 6 Consecutive Years


Questions on our public relations?

Ask us now.